SlideShare uma empresa Scribd logo
1 de 8
Baixar para ler offline
Part 1 – Preparing for the FDA Visit
• You asked for it… Wanted more review of the
steps involved

• This series is designed in parts
•
•
•
•
•

Part 1 – Preparing for the FDA
Part 2 – What to do when the FDA arrives
Part 3 – What to do while the FDA is there
Part 4 – What to do during closeout
Part 5 – What to do with the 483

This is Part 1 – Preparing for the FDA
People always ask me – “Troy, what is the best way to deal with
FDA issues?” I usually say…”Don’t have any”
That being said…there are things you can do to mitigate the
potential for you and your firm to have any serious FDA
problems.
Let’s start with the obvious:
• Did you have previous 483’s or Warning Letters? If so, did you
do everything to which you committed in the response? If
not, did you inform the FDA of the delay. During the audit is
not the time to find out you have issues…
• Will the next audit be – general GMP? For cause? PAI?
• If the inspection is going to be focused – you can focus your
attention to getting those things ready. Don’t forget – you
could always have a general inspection even during a PAI.
Your facility should always be ready for an inspection! But…it is
always a good idea to go through the facility to see how things look.
• Working in the factory every day can “dull” your senses to
problems that might have slowly developed over time
• Have someone “new” go through the facility
• Develop a “tour” plan for the areas – who will lead the tour in
different areas? What pathway to take (just remember – the FDA
can always go where they want – within reason)?
• Any signs of leaks in the ceiling? Cracked walls? Pealing Paint?
• All signage in place?
• Facility registration up to date?
• How does the exterior of the facility appear?
• Remediate anything possible!!
• Key is that everything should look organized and in CONTROL!
Look at how you are making the product(s) – specifically on the high
risk processes. If you have a PAI, focus on the product in the filing.
Are you in CONTROL?
How do you know?
Does the process match what you have filed?
Do the SOP’s conflict with the process?
Is your APR (annual product review) process up to date?

Have you maintained a good change control system?
Are people trained?
How do you control training – updates to SOPs?
Annual GMP training performed?
How do batch record errors look? Lots of errors or fairly clean?
Do the investigations often site “people” as the issue? If so,
then you have an issue.
Who are the folks that you will use as SME’s?
You need to check a lot of other items in preparation for the audit.
You know your system – check those areas that have potential for the
largest impact.
•
•
•
•
•
•

Warehouse practices
Customer complaints
Validation – equipment, process, cleaning, utilities, etc.
Lab operations
Calibration
Pest and rodent control

The key? Show you are in CONTROL!! How do you know it?
Call us at 513-860-3512
See our website at
www.Compliance-Insight.com
Send us an email at
info@Compliance-Insight.com

Thanks for watching!

Mais conteúdo relacionado

Semelhante a FDA audit series part 1, Preparing for the Audit

REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTMichael Swit
 
Preparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdpPreparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdpCarmita Depasquale
 
Problem solving
Problem solvingProblem solving
Problem solvingRob Graham
 
Root Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin StewartRoot Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin StewartASQ Reliability Division
 
Drug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentDrug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentMichael Swit
 
Shop floor 5's
Shop floor 5'sShop floor 5's
Shop floor 5'sKalacco
 
The FDA just called, Now What?
The FDA just called, Now What?The FDA just called, Now What?
The FDA just called, Now What?MasterControl
 
295910 633971289061398750
295910 633971289061398750295910 633971289061398750
295910 633971289061398750mefaiqahmed
 
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTMichael Swit
 
8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)nguyenanvuong2007
 
5S basic training ppt
5S basic training ppt5S basic training ppt
5S basic training pptbeskidek
 
5S Training Presentation
5S Training Presentation5S Training Presentation
5S Training PresentationParth Devariya
 

Semelhante a FDA audit series part 1, Preparing for the Audit (20)

REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
 
Kaizen
KaizenKaizen
Kaizen
 
Preparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdpPreparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdp
 
Problem solving
Problem solvingProblem solving
Problem solving
 
Root Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin StewartRoot Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin Stewart
 
Drug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentDrug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory Environment
 
Shop floor 5's
Shop floor 5'sShop floor 5's
Shop floor 5's
 
The FDA just called, Now What?
The FDA just called, Now What?The FDA just called, Now What?
The FDA just called, Now What?
 
295910 633971289061398750
295910 633971289061398750295910 633971289061398750
295910 633971289061398750
 
Pai
PaiPai
Pai
 
5 S Basic Training
5 S Basic Training5 S Basic Training
5 S Basic Training
 
BASIC OF TRAINING
BASIC OF TRAININGBASIC OF TRAINING
BASIC OF TRAINING
 
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
 
8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)
 
LEAN: 5 Keys to Success
LEAN: 5 Keys to SuccessLEAN: 5 Keys to Success
LEAN: 5 Keys to Success
 
5 why training_presentation
5 why training_presentation5 why training_presentation
5 why training_presentation
 
5s
5s5s
5s
 
5S basic training ppt
5S basic training ppt5S basic training ppt
5S basic training ppt
 
5s System
5s System5s System
5s System
 
5S Training Presentation
5S Training Presentation5S Training Presentation
5S Training Presentation
 

Mais de Compliance Insight, Inc. (12)

July 2015
July 2015July 2015
July 2015
 
GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.
 
About Compliance Insight Inc.
About Compliance Insight Inc.About Compliance Insight Inc.
About Compliance Insight Inc.
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
 
Basics of FDA GMP Training
Basics of FDA GMP TrainingBasics of FDA GMP Training
Basics of FDA GMP Training
 
FDA Audit - The Do and Don't List
FDA Audit - The Do and Don't ListFDA Audit - The Do and Don't List
FDA Audit - The Do and Don't List
 
FDA GMP Training - The Quality Audit
FDA GMP Training - The Quality AuditFDA GMP Training - The Quality Audit
FDA GMP Training - The Quality Audit
 
Top 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA ComplianceTop 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA Compliance
 
21 cfr, parts 210 211
21 cfr, parts 210 21121 cfr, parts 210 211
21 cfr, parts 210 211
 
FDA Warning Letter
FDA Warning LetterFDA Warning Letter
FDA Warning Letter
 
FDA 483
FDA 483FDA 483
FDA 483
 
Fda Inspection
Fda InspectionFda Inspection
Fda Inspection
 

Último

Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxWorkforce Group
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.ukaroemirsr
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toumarfarooquejamali32
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.mcshagufta46
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..dlewis191
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)tazeenaila12
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...Khaled Al Awadi
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 

Último (20)

Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.uk
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb to
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.A flour, rice and Suji company in Jhang.
A flour, rice and Suji company in Jhang.
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 

FDA audit series part 1, Preparing for the Audit

  • 1. Part 1 – Preparing for the FDA Visit
  • 2. • You asked for it… Wanted more review of the steps involved • This series is designed in parts • • • • • Part 1 – Preparing for the FDA Part 2 – What to do when the FDA arrives Part 3 – What to do while the FDA is there Part 4 – What to do during closeout Part 5 – What to do with the 483 This is Part 1 – Preparing for the FDA
  • 3. People always ask me – “Troy, what is the best way to deal with FDA issues?” I usually say…”Don’t have any” That being said…there are things you can do to mitigate the potential for you and your firm to have any serious FDA problems. Let’s start with the obvious: • Did you have previous 483’s or Warning Letters? If so, did you do everything to which you committed in the response? If not, did you inform the FDA of the delay. During the audit is not the time to find out you have issues… • Will the next audit be – general GMP? For cause? PAI? • If the inspection is going to be focused – you can focus your attention to getting those things ready. Don’t forget – you could always have a general inspection even during a PAI.
  • 4. Your facility should always be ready for an inspection! But…it is always a good idea to go through the facility to see how things look. • Working in the factory every day can “dull” your senses to problems that might have slowly developed over time • Have someone “new” go through the facility • Develop a “tour” plan for the areas – who will lead the tour in different areas? What pathway to take (just remember – the FDA can always go where they want – within reason)? • Any signs of leaks in the ceiling? Cracked walls? Pealing Paint? • All signage in place? • Facility registration up to date? • How does the exterior of the facility appear? • Remediate anything possible!! • Key is that everything should look organized and in CONTROL!
  • 5. Look at how you are making the product(s) – specifically on the high risk processes. If you have a PAI, focus on the product in the filing. Are you in CONTROL? How do you know? Does the process match what you have filed? Do the SOP’s conflict with the process? Is your APR (annual product review) process up to date? Have you maintained a good change control system?
  • 6. Are people trained? How do you control training – updates to SOPs? Annual GMP training performed? How do batch record errors look? Lots of errors or fairly clean? Do the investigations often site “people” as the issue? If so, then you have an issue. Who are the folks that you will use as SME’s?
  • 7. You need to check a lot of other items in preparation for the audit. You know your system – check those areas that have potential for the largest impact. • • • • • • Warehouse practices Customer complaints Validation – equipment, process, cleaning, utilities, etc. Lab operations Calibration Pest and rodent control The key? Show you are in CONTROL!! How do you know it?
  • 8. Call us at 513-860-3512 See our website at www.Compliance-Insight.com Send us an email at info@Compliance-Insight.com Thanks for watching!